Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
4.410
-0.120 (-2.65%)
Mar 9, 2026, 3:08 PM EDT - Market open
Atossa Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 14.42 | 13.5 | 14.04 | 12.61 | 11.31 | 8 | |
| Research & Development | 18.43 | 14.12 | 17.33 | 15.08 | 9.21 | 6.61 | |
| Operating Expenses | 32.86 | 27.62 | 31.38 | 27.69 | 20.52 | 14.61 | |
| Operating Income | -32.86 | -27.62 | -31.38 | -27.69 | -20.52 | -14.61 | |
| Interest & Investment Income | 2.77 | 4.05 | 4.34 | 0.88 | 0.01 | - | |
| Other Non Operating Income (Expenses) | -0.1 | -0.22 | -0.07 | -0.15 | -0.09 | -3.22 | |
| EBT Excluding Unusual Items | -30.18 | -23.79 | -27.1 | -26.96 | -20.61 | -17.83 | |
| Gain (Loss) on Sale of Investments | - | -1.71 | -2.99 | - | - | - | |
| Pretax Income | -30.18 | -25.5 | -30.09 | -26.96 | -20.61 | -17.83 | |
| Earnings From Continuing Operations | -30.18 | -25.5 | -30.09 | -26.96 | -20.61 | -17.83 | |
| Net Income | -30.18 | -25.5 | -30.09 | -26.96 | -20.61 | -17.83 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 4.5 | |
| Net Income to Common | -30.18 | -25.5 | -30.09 | -26.96 | -20.61 | -22.33 | |
| Shares Outstanding (Basic) | 9 | 8 | 8 | 8 | 8 | 1 | |
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 8 | 8 | 1 | |
| Shares Change (YoY) | 2.39% | -0.18% | -0.43% | 8.27% | 934.13% | 33.09% | |
| EPS (Basic) | -3.52 | -3.04 | -3.58 | -3.19 | -2.64 | -29.62 | |
| EPS (Diluted) | -3.52 | -3.04 | -3.58 | -3.19 | -2.64 | -29.62 | |
| Free Cash Flow | -26.29 | -21.05 | -20.96 | -20.79 | -16.48 | -11.58 | |
| Free Cash Flow Per Share | -3.07 | -2.51 | -2.49 | -2.46 | -2.11 | -15.36 | |
| EBITDA | -32.84 | -27.6 | -31.35 | -27.68 | -20.5 | -14.56 | |
| D&A For EBITDA | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.05 | |
| EBIT | -32.86 | -27.62 | -31.38 | -27.69 | -20.52 | -14.61 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.